Related Experiment Video
Updated: Aug 14, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Initial Experience With the Aeson Total Artificial Heart in Patients With Ventricular Septal Defect After Acute
Michal Nozdrzykowski1, Olivier Bouchot2, Andre Vincentelli3
1Department of Cardiac Surgery, University of Leipzig, Heart Center, Leipzig, Germany.
Artificial Organs
|August 13, 2026
Summary
The Aeson total artificial heart (TAH) offers a viable bridge-to-transplant option for patients with irreparable post-myocardial infarction ventricular septal defects (VSD). This approach achieved good short- to mid-term survival in a challenging patient group.
Area of Science:
- Cardiology
- Mechanical Circulatory Support
- Cardiac Surgery
Background:
- Post-myocardial infarction ventricular septal defect (VSD) is a rare, lethal complication.
- Surgical repair is often not feasible due to extensive septal destruction.
- This study explores the Aeson total artificial heart (TAH) for irreparable VSD.
